Literature DB >> 28968824

Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.

Catherine Godfrey1, Marina Bobkova2, Charles Boucher3, Giovanni Ravasi4, Ping Chen5, Fujie Zhang6, Yasong Wu7, Rami Kantor8.   

Abstract

In diverse global regions with significant human immunodeficiency virus (HIV) burden, programmatic, cultural, and provider-, patient-, and virus-related factors may result in HIV drug resistance, with global implications. This article reviews such common and unique challenges in Russia, Latin America and the Caribbean, China, and India, to suggest potential solutions. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  China; HIV drug resistance; India; Latin America; Russia

Mesh：

Substances：

Year:  2017        PMID： 28968824      PMCID： PMC5853282          DOI： 10.1093/infdis/jix408

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   7.759


  38 in total

1.  Short-term effectiveness and safety of third-line antiretroviral regimens among patients in Western India.

Authors:  Sanjay N Pujari; Abhimanyu Makane; Abhijit Lodha; Vivek Bele; Kedar Joshi
Journal:  J Acquir Immune Defic Syndr       Date:  2014-02-01       Impact factor: 3.731

2.  Prevalence of drug resistance in human immunodeficiency virus type 1-infected treatment-naive children in Pune, India.

Authors:  Mukesh Kumar; Sourav Sen; Rakesh K Gupta; Devidas Chaturbhuj; Srikanth P Tripathy; Ramesh S Paranjape
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-07       Impact factor: 2.205

3.  Injection Drug Network Characteristics Are Important Markers of HIV Risk Behavior and Lack of Viral Suppression.

Authors:  Javier A Cepeda; Sunil S Solomon; Aylur K Srikrishnan; Allison M McFall; Muniratnam Suresh Kumar; Canjeevaram K Vasudevan; Santhanam Anand; David D Celentano; Gregory M Lucas; Shruti H Mehta
Journal:  J Acquir Immune Defic Syndr       Date:  2017-07-01       Impact factor: 3.731

4.  The influence of stigma on HIV risk behavior among men who have sex with men in Chennai, India.

Authors:  Beena Thomas; Matthew J Mimiaga; Kenneth H Mayer; Nicholas S Perry; Soumya Swaminathan; Steven A Safren
Journal:  AIDS Care       Date:  2012-04-23

5.  Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India.

Authors:  Venkatesan Chakrapani; Jaikumar Velayudham; Murali Shunmugam; Peter A Newman; Robert Dubrow
Journal:  AIDS Care       Date:  2013-11-28

6.  Genotypic HIV-1 Drug Resistance Among Patients Failing Tenofovir-Based First-Line HAART in South India.

Authors:  Thongadi Ramesh Dinesha; Selvamurthi Gomathi; Jayaseelan Boobalan; Sathasivam Sivamalar; Sunil S Solomon; Ambrose Pradeep; Selvamuthu Poongulali; Suniti Solomon; Pachamuthu Balakrishnan; Shanmugam Saravanan
Journal:  AIDS Res Hum Retroviruses       Date:  2016-07-14       Impact factor: 2.205

7.  Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India.

Authors:  Madhavan Vidya; Shanmugam Saravanan; Shanmugasundaram Uma; Nagalingeswaran Kumarasamy; Solomon S Sunil; Rami Kantor; David Katzenstein; Bharat Ramratnam; Kenneth H Mayer; Solomon Suniti; Pachamuthu Balakrishnan
Journal:  Antivir Ther       Date:  2009

8.  The cascade of HIV care in Russia, 2011-2013.

Authors:  Anastasia Pokrovskaya; Anna Popova; Natalia Ladnaya; Oleg Yurin
Journal:  J Int AIDS Soc       Date:  2014-11-02       Impact factor: 5.396

9.  Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China.

Authors:  Zhongbao Zuo; Shu Liang; Xianguang Sun; Scottie Bussell; Jing Yan; Wei Kan; Xuebing Leng; Lingjie Liao; Yuhua Ruan; Yiming Shao; Hui Xing
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

10.  Outcome of patients on second line antiretroviral therapy under programmatic condition in India.

Authors:  Jaya Chakravarty; Shyam Sundar; Ankita Chourasia; Pallav Narayan Singh; Swarali Kurle; Srikanth P Tripathy; Devidas N Chaturbhuj; Madhukar Rai; Amit Kumar Agarwal; Rabindra Nath Mishra; Ramesh S Paranjape
Journal:  BMC Infect Dis       Date:  2015-11-14       Impact factor: 3.090
View more
  2 in total

1.  Drug Resistance to HIV-1 Integrase Inhibitors Among Treatment-Naive Patients in Beijing, China.

Authors:  Fengting Yu; Qun Li; Linghang Wang; Hongxin Zhao; Hao Wu; Siyuan Yang; Yunxia Tang; Jiang Xiao; Fujie Zhang
Journal:  Pharmgenomics Pers Med       Date:  2022-03-10

2.  Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Baoding, Hebei province, China.

Authors:  Weiguang Fan; Xiaodong Wang; Yuchen Zhang; Juan Meng; Miaomiao Su; Xuegang Yang; Haoxi Shi; Penghui Shi; Xinli Lu
Journal:  Front Genet       Date:  2022-09-14       Impact factor: 4.772
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.